Eva Feldman

rdf:langString Eva Feldman

rdf:langString Eva Lucille Feldman, M.D., Ph.D., F.A.A.N., F.A.N.A. is an American physician-scientist and one of the world’s leading authorities on neurodegenerative disease. Currently, she serves as the Russell N. DeJong Professor of Neurology at the University of Michigan, as well as Director of the NeuroNetwork for Emerging Therapies and ALS Center of Excellence at Michigan Medicine. She was also recently named the James W. Albers Distinguished University Professor of Neurology. Feldman has made contributions to biomedical research and clinical care in many critical areas of neurodegenerative disease. Her primary focus has been on , Alzheimer's disease, cognitive decline, and the neurologic complications of diabetes and obesity, as well as how environmental toxins affect the nervous system. She also has conducted pioneering research on developing stem cell therapies to treat these diseases. She is annually listed in Best Doctors in America and is a member of the Association of American Physicians and National Academy of Medicine. She is a Fellow of the American Association for the Advancement of Science. Feldman has authored over 500 articles, 70 book chapters (Google Scholar h-index = 109) with >45,000 citations. She has been continuously NIH funded since 1989 and has received numerous awards and honors throughout her remarkable career.